PureTech Health Plc - ADR Stock News
$17.25
9.50%
today
Nasdaq,
Apr 04, 08:29 pm CET
PureTech Health Plc - ADR Stock News
Neutral
Business Wire
●
24 days ago
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair.
Neutral
Business Wire
●
about 2 months ago
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform.
Neutral
Business Wire
●
2 months ago
BOSTON--(BUSINESS WIRE)--PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine.
Neutral
Business Wire
●
3 months ago
BOSTON--(BUSINESS WIRE)--PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML).
Neutral
Business Wire
●
3 months ago
BOSTON--(BUSINESS WIRE)--PureTech Appoints UBS as UK Corporate Broker.
Neutral
Business Wire
●
4 months ago
BOSTON--(BUSINESS WIRE)--PureTech's Deupirfenidone Slowed Lung Function Decline in People w/ IPF, Achieving the Primary & Key Secondary Endpoints in ELEVATE IPF Phase 2b Trial.
Neutral
Business Wire
●
4 months ago
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024.
Neutral
Business Wire
●
4 months ago
BOSTON--(BUSINESS WIRE)--PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
